{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:50:37Z","timestamp":1790869837821,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"crossref","award":["C09-2313"],"award-info":[{"award-number":["C09-2313"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00467-016-3496-0","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T07:15:07Z","timestamp":1475824507000},"page":"297-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome"],"prefix":"10.1007","volume":"32","author":[{"given":"Dineke","family":"Westra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena B.","family":"Volokhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate G.","family":"van der Molen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea J. A. M.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Jeronimus-Klaasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop","family":"Goertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Gracchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiske M.","family":"Dorresteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia H. M.","family":"Bouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy G.","family":"Keijzer-Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna A. E.","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap A.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert P.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C. A. J.","family":"van de Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,7]]},"reference":[{"key":"3496_CR1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","volume":"70","author":"N Besbas","year":"2006","unstructured":"Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB, European Paediatric Research Group for HUS (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70:423\u2013431","journal-title":"Kidney Int"},{"key":"3496_CR2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654\u2013666","journal-title":"N Engl J Med"},{"key":"3496_CR3","first-page":"121","volume":"70","author":"D Westra","year":"2012","unstructured":"Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC (2012) A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med 70:121\u2013129","journal-title":"Neth J Med"},{"key":"3496_CR4","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","volume":"41","author":"V Fremeaux-Bacchi","year":"2004","unstructured":"Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, Vigneau C, Kuypers D, Boudailliez B, Loirat C, Rondeau E, Fridman WH (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41:e84","journal-title":"J Med Genet"},{"key":"3496_CR5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang CJ, Liszewski MK, Kavanagh D, Atkinson JP, Remuzzi G, International Registry of Recurrent and Familial HUS\/TTP (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108:1267\u20131279","journal-title":"Blood"},{"key":"3496_CR6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","volume":"104","author":"E Goicoechea de Jorge","year":"2007","unstructured":"Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, Carreras L, Arranz EA, Garrido CA, Lopez-Trascasa M, Sanchez-Corral P, Morgan BP, Rodriguez de Cordoba S (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 104:240\u2013245","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3496_CR7","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","volume":"112","author":"V Fremeaux-Bacchi","year":"2008","unstructured":"Fremeaux-Bacchi V, Miller EC, Liszewski MK, Strain L, Blouin J, Brown AL, Moghal N, Kaplan BS, Weiss RA, Lhotta K, Kapur G, Mattoo T, Nivet H, Wong W, Gie S, Hurault de Ligny B, Fischbach M, Gupta R, Hauhart R, Meunier V, Loirat C, Dragon-Durey MA, Fridman WH, Janssen BJ, Goodship TH, Atkinson JP (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112:4948\u20134952","journal-title":"Blood"},{"key":"3496_CR8","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1093\/ndt\/gfq010","volume":"25","author":"D Westra","year":"2010","unstructured":"Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L (2010) Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS). Nephrol Dial Transplant 25:2195\u20132202","journal-title":"Nephrol Dial Transplant"},{"key":"3496_CR9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00467-012-2183-z","volume":"27","author":"E Volokhina","year":"2012","unstructured":"Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L (2012) Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding. Pediatr Nephrol 27:1519\u20131524","journal-title":"Pediatr Nephrol"},{"key":"3496_CR10","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","volume":"100","author":"A Richards","year":"2003","unstructured":"Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Muslumanoglu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 100:12966\u201312971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3496_CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM (2009) Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 361:345\u2013357","journal-title":"N Engl J Med"},{"key":"3496_CR12","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","volume":"111","author":"M Jozsi","year":"2008","unstructured":"Jozsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C (2008) Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency. Blood 111:1512\u20131514","journal-title":"Blood"},{"key":"3496_CR13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire M, Fremeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, Nurnberg G, Altmuller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, Nurnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP (2013) Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet 45:531\u2013536","journal-title":"Nat Genet"},{"key":"3496_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","volume":"25","author":"F Bu","year":"2014","unstructured":"Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ (2014) Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 25:55\u201364","journal-title":"J Am Soc Nephrol"},{"key":"3496_CR15","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2012-2581","volume":"132","author":"M Komhoff","year":"2013","unstructured":"Komhoff M, Roofthooft MT, Westra D, Teertstra TK, Losito A, van de Kar NC, Berger RM (2013) Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency. Pediatrics 132:e540\u2013e544","journal-title":"Pediatrics"},{"key":"3496_CR16","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","volume":"182","author":"D Orth","year":"2009","unstructured":"Orth D, Khan AB, Naim A, Grif K, Brockmeyer J, Karch H, Joannidis M, Clark SJ, Day AJ, Fidanzi S, Stoiber H, Dierich MP, Zimmerhackl LB, Wurzner R (2009) Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 182:6394\u20136400","journal-title":"J Immunol"},{"key":"3496_CR17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","volume":"187","author":"M Morigi","year":"2011","unstructured":"Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C (2011) Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187:172\u2013180","journal-title":"J Immunol"},{"key":"3496_CR18","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.4049\/jimmunol.178.9.5848","volume":"178","author":"S Hammerschmidt","year":"2007","unstructured":"Hammerschmidt S, Agarwal V, Kunert A, Haelbich S, Skerka C, Zipfel PF (2007) The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J Immunol 178:5848\u20135858","journal-title":"J Immunol"},{"key":"3496_CR19","first-page":"168","volume":"13","author":"L Monnens","year":"1980","unstructured":"Monnens L, Molenaar J, Lambert PH, Proesmans W, van Munster P (1980) The complement system in hemolytic-uremic syndrome in childhood. Clin Nephrol 13:168\u2013171","journal-title":"Clin Nephrol"},{"key":"3496_CR20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000187063","volume":"62","author":"WL Robson","year":"1992","unstructured":"Robson WL, Leung AK, Fick GH, McKenna AI (1992) Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 62:296\u2013299","journal-title":"Nephron"},{"key":"3496_CR21","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","volume":"4","author":"JM Thurman","year":"2009","unstructured":"Thurman JM, Marians R, Emlen W, Wood S, Smith C, Akana H, Holers VM, Lesser M, Kline M, Hoffman C, Christen E, Trachtman H (2009) Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1920\u20131924","journal-title":"Clin J Am Soc Nephrol"},{"key":"3496_CR22","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","volume":"117","author":"AL Stahl","year":"2011","unstructured":"Stahl AL, Sartz L, Karpman D (2011) Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 117:5503\u20135513","journal-title":"Blood"},{"key":"3496_CR23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ndt\/gfw078","volume":"31","author":"T Ahlenstiel-Grunow","year":"2016","unstructured":"Ahlenstiel-Grunow T, Hachmeister S, Bange FC, Wehling C, Kirschfink M, Bergmann C, Pape L (2016) Systemic complement activation and complement gene analysis in enterohaemorrhagic Escherichia coli-associated paediatric haemolytic uraemic syndrome. Nephrol Dial Transplant 31:1114\u20131121","journal-title":"Nephrol Dial Transplant"},{"key":"3496_CR24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","volume":"24","author":"G Ariceta","year":"2009","unstructured":"Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB, European Paediatric Study Group for HUS (2009) Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 24:687\u2013696","journal-title":"Pediatr Nephrol"},{"key":"3496_CR25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-62703-724-2_20","volume":"1100","author":"MA Dragon-Durey","year":"2014","unstructured":"Dragon-Durey MA, Blanc C, Roumenina LT, Poulain N, Ngo S, Bordereau P, Fremeaux-Bacchi V (2014) Anti-factor H autoantibodies assay. Methods Mol Biol 1100:249\u2013256","journal-title":"Methods Mol Biol"},{"key":"3496_CR26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1472-765X.2004.01499.x","volume":"38","author":"H Chart","year":"2004","unstructured":"Chart H, Perry NT (2004) The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome. Lett Appl Microbiol 38:351\u2013354","journal-title":"Lett Appl Microbiol"},{"key":"3496_CR27","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1373\/clinchem.2010.148809","volume":"56","author":"I Zegers","year":"2010","unstructured":"Zegers I, Keller T, Schreiber W, Sheldon J, Albertini R, Blirup-Jensen S, Johnson M, Trapmann S, Emons H, Merlini G, Schimmel H (2010) Characterization of the new serum protein reference material ERM-DA470k\/IFCC: value assignment by immunoassay. Clin Chem 56:1880\u20131888","journal-title":"Clin Chem"},{"key":"3496_CR28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molimm.2013.05.221","volume":"56","author":"G Bergseth","year":"2013","unstructured":"Bergseth G, Ludviksen JK, Kirschfink M, Giclas PC, Nilsson B, Mollnes TE (2013) An international serum standard for application in assays to detect human complement activation products. Mol Immunol 56:232\u2013239","journal-title":"Mol Immunol"},{"key":"3496_CR29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2362.2003.01153.x","volume":"33","author":"AJ Branten","year":"2003","unstructured":"Branten AJ, Kock-Jansen M, Klasen IS, Wetzels JF (2003) Urinary excretion of complement C3d in patients with renal diseases. Eur J Clin Investig 33:449\u2013456","journal-title":"Eur J Clin Investig"},{"key":"3496_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00467-012-2312-8","volume":"28","author":"D Westra","year":"2013","unstructured":"Westra D, Dorresteijn EM, Beishuizen A, van den Heuvel LP, Brons PP, van de Kar NC (2013) The challenge of managing hemophilia A and STEC-induced hemolytic uremic syndrome. Pediatr Nephrol 28:349\u2013352","journal-title":"Pediatr Nephrol"},{"key":"3496_CR31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00467-012-2130-z","volume":"27","author":"EM Dorresteijn","year":"2012","unstructured":"Dorresteijn EM, van de Kar NC, Cransberg K (2012) Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count. Pediatr Nephrol 27:1193\u20131195","journal-title":"Pediatr Nephrol"},{"key":"3496_CR32","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nurnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368:2169\u20132181","journal-title":"N Engl J Med"},{"key":"3496_CR33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/cei.12426","volume":"181","author":"EB Volokhina","year":"2015","unstructured":"Volokhina EB, Westra D, van der Velden TJ, van de Kar NC, Mollnes TE, van den Heuvel LP (2015) Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission. Clin Exp Immunol 181:306\u2013313","journal-title":"Clin Exp Immunol"},{"key":"3496_CR34","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","volume":"124","author":"M Noris","year":"2014","unstructured":"Noris M, Galbusera M, Gastoldi S, Macor P, Banterla F, Bresin E, Tripodo C, Bettoni S, Donadelli R, Valoti E, Tedesco F, Amore A, Coppo R, Ruggenenti P, Gotti E, Remuzzi G (2014) Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. Blood 124:1715\u20131726","journal-title":"Blood"},{"key":"3496_CR35","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844\u20131859","journal-title":"Clin J Am Soc Nephrol"},{"key":"3496_CR36","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00467-012-2131-y","volume":"27","author":"LM Geerdink","year":"2012","unstructured":"Geerdink LM, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Komhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC (2012) Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics. Pediatr Nephrol 27:1283\u20131291","journal-title":"Pediatr Nephrol"},{"key":"3496_CR37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/infdis\/160.1.58","volume":"160","author":"P Brandtzaeg","year":"1989","unstructured":"Brandtzaeg P, Mollnes TE, Kierulf P (1989) Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis 160:58\u201365","journal-title":"J Infect Dis"},{"key":"3496_CR38","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1128\/IAI.00488-10","volume":"78","author":"D Orth","year":"2010","unstructured":"Orth D, Ehrlenbach S, Brockmeyer J, Khan AB, Huber G, Karch H, Sarg B, Lindner H, Wurzner R (2010) EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3\/C3b and C5. Infect Immun 78:4294\u20134301","journal-title":"Infect Immun"},{"key":"3496_CR39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.ajkd.2007.08.030","volume":"51","author":"MM Edey","year":"2008","unstructured":"Edey MM, Mead PA, Saunders RE, Strain L, Perkins SJ, Goodship TH, Kanagasundaram NS (2008) Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness. Am J Kidney Dis 51:487\u2013490","journal-title":"Am J Kidney Dis"},{"key":"3496_CR40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","volume":"111","author":"CJ Fang","year":"2008","unstructured":"Fang CJ, Fremeaux-Bacchi V, Liszewski MK, Pianetti G, Noris M, Goodship TH, Atkinson JP (2008) Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 111:624\u2013632","journal-title":"Blood"},{"key":"3496_CR41","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/ajt.12297","volume":"13","author":"M Alberti","year":"2013","unstructured":"Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, Thaiss F, Remuzzi G, Noris M (2013) Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations. Am J Transplant 13:2201\u20132206","journal-title":"Am J Transplant"},{"key":"3496_CR42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2431-14-278","volume":"14","author":"N McCoy","year":"2014","unstructured":"McCoy N, Weaver DJ Jr (2014) Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities. BMC Pediatr 14:278","journal-title":"BMC Pediatr"},{"key":"3496_CR43","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.1755","volume":"10","author":"J Wu","year":"2009","unstructured":"Wu J, Wu YQ, Ricklin D, Janssen BJ, Lambris JD, Gros P (2009) Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol 10:728\u2013733","journal-title":"Nat Immunol"},{"key":"3496_CR44","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/ng.2741","volume":"45","author":"JM Seddon","year":"2013","unstructured":"Seddon JM, Yu Y, Miller EC, Reynolds R, Tan PL, Gowrisankar S, Goldstein JI, Triebwasser M, Anderson HE, Zerbib J, Kavanagh D, Souied E, Katsanis N, Daly MJ, Atkinson JP, Raychaudhuri S (2013) Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet 45:1366\u20131370","journal-title":"Nat Genet"},{"key":"3496_CR45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/jmbi.2001.5337","volume":"316","author":"SJ Perkins","year":"2002","unstructured":"Perkins SJ, Goodship TH (2002) Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site. J Mol Biol 316:217\u2013224","journal-title":"J Mol Biol"},{"key":"3496_CR46","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/jmedgenet-2014-102498","volume":"51","author":"FH Sansbury","year":"2014","unstructured":"Sansbury FH, Cordell HJ, Bingham C, Bromilow G, Nicholls A, Powell R, Shields B, Smyth L, Warwicker P, Strain L, Wilson V, Goodship JA, Goodship TH, Turnpenny PD (2014) Factors determining penetrance in familial atypical haemolytic uraemic syndrome. J Med Genet 51:756\u2013764","journal-title":"J Med Genet"},{"key":"3496_CR47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","volume":"29","author":"Y Delmas","year":"2014","unstructured":"Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Helou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C (2014) Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant 29:565\u2013572","journal-title":"Nephrol Dial Transplant"},{"key":"3496_CR48","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","volume":"27","author":"JT Kielstein","year":"2012","unstructured":"Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nurnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R, Collaborators of the DGfN STEC-HUS registry (2012) Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 27:3807\u20133815","journal-title":"Nephrol Dial Transplant"},{"key":"3496_CR49","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","volume":"345","author":"J Menne","year":"2012","unstructured":"Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmuller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Munte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schocklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhoner P, Wiesner M, Zeissig S, Buning J, Schiffer M, Kuehbacher T, EHEC-HUS consortium (2012) Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case\u2013control study. BMJ 345:e4565","journal-title":"BMJ"},{"key":"3496_CR50","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1055\/s-0034-1375295","volume":"40","author":"R Wurzner","year":"2014","unstructured":"Wurzner R, Riedl M, Rosales A, Orth-Holler D (2014) Treatment of enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome (eHUS). Semin Thromb Hemost 40:508\u2013516","journal-title":"Semin Thromb Hemost"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3496-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-016-3496-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3496-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:35:33Z","timestamp":1498336533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-016-3496-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,7]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3496"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3496-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,7]]}}}